Chad May

3.6k total citations · 1 hit paper
35 papers, 2.7k citations indexed

About

Chad May is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Chad May has authored 35 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 13 papers in Oncology and 12 papers in Genetics. Recurrent topics in Chad May's work include Virus-based gene therapy research (11 papers), CAR-T cell therapy research (8 papers) and CRISPR and Genetic Engineering (8 papers). Chad May is often cited by papers focused on Virus-based gene therapy research (11 papers), CAR-T cell therapy research (8 papers) and CRISPR and Genetic Engineering (8 papers). Chad May collaborates with scholars based in United States, France and Germany. Chad May's co-authors include Michel Sadelain, Stefano Rivella, J Callegari, Glenn Heller, Amy Chadburn, K M Gaensler, Lucio Luzzatto, Hans‐Peter Gerber, Puja Sapra and Isabelle Rivière and has published in prestigious journals such as Nature, Blood and Nature Biotechnology.

In The Last Decade

Chad May

35 papers receiving 2.6k citations

Hit Papers

Endothelial Cells Are Essential for the Self-Renewal and ... 2010 2026 2015 2020 2010 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chad May United States 22 1.4k 791 679 568 541 35 2.7k
Gerard Wagemaker Netherlands 39 1.6k 1.2× 1.1k 1.4× 883 1.3× 465 0.8× 1.5k 2.8× 146 4.2k
Kevin T. McDonagh United States 25 1.5k 1.1× 844 1.1× 690 1.0× 254 0.4× 524 1.0× 60 2.8k
Patrick A. Zweidler‐McKay United States 35 1.8k 1.3× 355 0.4× 1.1k 1.6× 258 0.5× 839 1.6× 128 3.7k
Ronald Berenson United States 22 841 0.6× 569 0.7× 608 0.9× 375 0.7× 937 1.7× 58 2.1k
Birgit M. Reipert Austria 25 827 0.6× 422 0.5× 429 0.6× 306 0.5× 1.3k 2.4× 91 2.7k
Edward D. Ball United States 31 1.2k 0.9× 378 0.5× 1.2k 1.8× 364 0.6× 1.1k 2.1× 176 3.5k
Monica Doedens Canada 20 1.3k 1.0× 582 0.7× 827 1.2× 736 1.3× 1.7k 3.1× 28 3.2k
Eric R. Lechman Canada 25 2.2k 1.6× 745 0.9× 673 1.0× 274 0.5× 827 1.5× 55 3.8k
Carol H. Miao United States 31 1.9k 1.4× 1.8k 2.3× 850 1.3× 140 0.2× 687 1.3× 83 3.4k
Michael P. Rettig United States 27 977 0.7× 257 0.3× 1.4k 2.0× 380 0.7× 1.8k 3.3× 122 3.5k

Countries citing papers authored by Chad May

Since Specialization
Citations

This map shows the geographic impact of Chad May's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chad May with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chad May more than expected).

Fields of papers citing papers by Chad May

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chad May. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chad May. The network helps show where Chad May may publish in the future.

Co-authorship network of co-authors of Chad May

This figure shows the co-authorship network connecting the top 25 collaborators of Chad May. A scholar is included among the top collaborators of Chad May based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chad May. Chad May is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Degenhardt, Jeremiah D., Pui Seto, Jessica Krakow, et al.. (2022). Regression of EGFR positive established solid tumors in mice with the conditionally active T cell engager TAK-186. Journal for ImmunoTherapy of Cancer. 10(6). e004336–e004336. 10 indexed citations
2.
Zhong, Wenyan, Jeremy S. Myers, Fang Wang, et al.. (2020). Comparison of the molecular and cellular phenotypes of common mouse syngeneic models with human tumors. BMC Genomics. 21(1). 2–2. 113 indexed citations
3.
Fisher, Timothy S., Andrea T. Hooper, Justin Lucas, et al.. (2017). A CD3-bispecific molecule targeting P-cadherin demonstrates T cell-mediated regression of established solid tumors in mice. Cancer Immunology Immunotherapy. 67(2). 247–259. 31 indexed citations
4.
Gerber, Hans‐Peter, Puja Sapra, Frank Loganzo, & Chad May. (2015). Combining antibody–drug conjugates and immune-mediated cancer therapy: What to expect?. Biochemical Pharmacology. 102. 1–6. 141 indexed citations
5.
May, Chad, Puja Sapra, & Hans‐Peter Gerber. (2012). Advances in bispecific biotherapeutics for the treatment of cancer. Biochemical Pharmacology. 84(9). 1105–1112. 61 indexed citations
6.
Butler, Jason M., Daniel J. Nolan, Eva Vertes, et al.. (2010). Endothelial Cells Are Essential for the Self-Renewal and Repopulation of Notch-Dependent Hematopoietic Stem Cells. Cell stem cell. 6(3). 251–264. 488 indexed citations breakdown →
7.
Penack, Olaf, Erik Henke, David Suh, et al.. (2010). Inhibition of Neovascularization to Simultaneously Ameliorate Graft-vs-Host Disease and Decrease Tumor Growth. JNCI Journal of the National Cancer Institute. 102(12). 894–908. 48 indexed citations
8.
McDevitt, Michael R., Alessandro Ruggiero, Carlos H. Villa, et al.. (2010). Imaging and treating tumor vasculature with targeted radiolabeled carbon nanotubes. International Journal of Nanomedicine. 5. 783–783. 123 indexed citations
9.
Jaggi, Jaspreet Singh, Erik Henke, Surya V. Seshan, et al.. (2007). Selective Alpha-Particle Mediated Depletion of Tumor Vasculature with Vascular Normalization. PLoS ONE. 2(3). e267–e267. 44 indexed citations
10.
May, Chad, Jacqueline Doody, Rashed Abdullah, et al.. (2005). Identification of a transiently exposed VE-cadherin epitope that allows for specific targeting of an antibody to the tumor neovasculature. Blood. 105(11). 4337–4344. 80 indexed citations
11.
Belur, Lalitha R., et al.. (2005). Methotrexate Preconditioning Allows Sufficient Engraftment to Confer Drug Resistance in Mice Transplanted with Marrow Expressing Drug-Resistant Dihydrofolate Reductase Activity. Journal of Pharmacology and Experimental Therapeutics. 314(2). 668–674. 9 indexed citations
12.
Sadelain, Michel, Leszek Lisowski, Selda Samakoglu, et al.. (2005). Progress Toward the Genetic Treatment of the β‐Thalassemias. Annals of the New York Academy of Sciences. 1054(1). 78–91. 27 indexed citations
13.
Rivella, Stefano, Chad May, Amy Chadburn, Isabelle Rivière, & Michel Sadelain. (2003). A novel murine model of Cooley anemia and its rescue by lentiviral-mediated human β-globin gene transfer. Blood. 101(8). 2932–2939. 173 indexed citations
14.
Koehne, Guenther, Mikhail Doubrovin, Ekaterina Doubrovina, et al.. (2003). Serial in vivo imaging of the targeted migration of human HSV-TK-transduced antigen-specific lymphocytes. Nature Biotechnology. 21(4). 405–413. 179 indexed citations
15.
MacKenzie, Karen L., Sonia Franco, Afzal J. Naiyer, et al.. (2002). Multiple stages of malignant transformation of human endothelial cells modelled by co-expression of telomerase reverse transcriptase, SV40 T antigen and oncogenic N-ras. Oncogene. 21(27). 4200–4211. 56 indexed citations
16.
May, Chad. (2001). A Promising Genetic Approach to the Treatment of b-Thalassemia. Trends in Cardiovascular Medicine. 11(7). 276–280. 8 indexed citations
17.
May, Chad, Stefano Rivella, J Callegari, et al.. (2000). Therapeutic haemoglobin synthesis in β-thalassaemic mice expressing lentivirus-encoded human β-globin. Nature. 406(6791). 82–86. 446 indexed citations
18.
Sadelain, Michel, Chad May, Stefano Rivella, & Julia Glade Bender. (1999). Basic Principles of Gene Transfer inHematopoietic Stem Cells. PubMed. 36. 1–19. 4 indexed citations
19.
May, Chad, et al.. (1999). Methotrexate resistance conferred by transplantation of drug-resistant transgenic marrow cells fractionated bycounterflow elutriation. Bone Marrow Transplantation. 24(8). 815–821. 2 indexed citations
20.
May, Chad, Roland Günther, & R. Scott McIvor. (1995). Protection of mice from lethal doses of methotrexate by transplantation with transgenic marrow expressing drug-resistant dihydrofolate reductase activity. Blood. 86(6). 2439–2448. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026